Information on infliximab
NHS Choices Medical Reference
It's important to go to a reliable source for more information on ulcerative colitis.
The National Institute for Health and Clinical Excellence (NICE) has produced healthcare guidelines on the treatment of ulcerative colitis with infliximab, a medication that affects the immune response.
This guidance outlines NICE's main recommendations on when infliximab should be used to treat people with ulcerative colitis in the NHS in England and Wales, when the condition would normally be managed without the person needing to stay in hospital overnight or have urgent surgery.
Download the NICE guidance on infliximab (links to an external site).